Literature DB >> 8115639

Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US.

J M Rubin1, R O Bude, P L Carson, R L Bree, R S Adler.   

Abstract

PURPOSE: The authors present a preliminary report to demonstrate a new color Doppler (CD) ultrasonography (US) technique called power Doppler (PD), which displays the total integrated Doppler power in color, and to compare PD with CD imaging, which generally displays an estimate of the mean Doppler frequency shift.
MATERIALS AND METHODS: Two standard commercial US scanners that encode the integrated power in the Doppler signal in color were used to demonstrate PD. A standard nonflow-containing US phantom, a normal right kidney, and a torsive and normal contralateral testis were scanned in the power mode. In the phantom and kidney, results with CD and PD were directly compared.
RESULTS: PD does not alias, is relatively angle independent, and displays background noise in a way that increases the usable dynamic range of a US scanner. This extended dynamic range should increase machine sensitivity and may demonstrate increased flow in certain circumstances.
CONCLUSION: PD is a new CD imaging imaging mode that might be superior to CD in some cases.

Entities:  

Mesh:

Year:  1994        PMID: 8115639     DOI: 10.1148/radiology.190.3.8115639

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  89 in total

1.  Value of contrast-enhanced power Doppler ultrasonography (US) of the metacarpophalangeal joints on rheumatoid arthritis.

Authors:  Andrea Klauser; Ferdinand Frauscher; Michael Schirmer
Journal:  Eur Radiol       Date:  2003-06-19       Impact factor: 5.315

2.  Carotid turbulent flow observed by convergent color Doppler flowmetry in silent cerebral infarction.

Authors:  Mie Ohyama; Katsufumi Mizushige; Hideo Ohyama; Tsutomu Takahashi; Naohisa Hosomi; Shin-Ichiro Ichihara; Masakazu Kohno
Journal:  Int J Cardiovasc Imaging       Date:  2002-04       Impact factor: 2.357

Review 3.  Three dimensional ultrasound and prostate cancer.

Authors:  S S Mehta; A R Azzouzi; F C Hamdy
Journal:  World J Urol       Date:  2004-11-12       Impact factor: 4.226

4.  Correlation between computerised findings and Newman's scaling on vascularity using power Doppler ultrasonography imaging and its predictive value in patients with plantar fasciitis.

Authors:  H Chen; H M Ho; M Ying; S N Fu
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

5.  Power Doppler ultrasound assessment of follicular vascularity in the early follicular phase and its relationship with outcome of in vitro fertilization.

Authors:  S M Shrestha; M F Costello; P Sjoblom; G McNally; M Bennett; S J Steigrad; G J Hughes
Journal:  J Assist Reprod Genet       Date:  2006-04-22       Impact factor: 3.412

6.  Longitudinal assessment of ovarian perifollicular and endometrial vascularity by power Doppler ultrasound in pregnant and non-pregnant cycles in the IVF setting.

Authors:  S M Shrestha; M F Costello; P Sjoblom; G McNally; M J Bennett; S J Steigrad; G J Hughes
Journal:  J Assist Reprod Genet       Date:  2004-11       Impact factor: 3.412

Review 7.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 8.  Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes.

Authors:  Takashi Nakamura; Misa Sumi
Journal:  Eur Radiol       Date:  2007-01-25       Impact factor: 5.315

9.  Role of power Doppler sonography in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis.

Authors:  C Shanmugavel; Kushaljit Singh Sodhi; Manavjit Singh Sandhu; R Sidhu; Surjit Singh; Sudha Katariya; N Khandelwal
Journal:  Rheumatol Int       Date:  2007-11-07       Impact factor: 2.631

Review 10.  Ultrasound in the evaluation of the inflammatory myopathies.

Authors:  Ronald S Adler; Giovanna Garofalo
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.